These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29540471)

  • 1. Outcomes After Continuous-Flow Left Ventricular Assist Device Implantation as Destination Therapy at Transplant Versus Nontransplant Centers.
    Brinkley DM; DeNofrio D; Ruthazer R; Vest AR; Kapur NK; Couper GS; Kiernan MS
    Circ Heart Fail; 2018 Mar; 11(3):e004384. PubMed ID: 29540471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
    J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure.
    Lala A; Rowland JC; Ferket BS; Gelijns AC; Bagiella E; Pinney SP; Moskowitz AJ; Miller MA; Pagani FD; Mancini DM
    JAMA Cardiol; 2020 Jun; 5(6):652-659. PubMed ID: 32293643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure.
    Miller PE; Caraballo C; Ravindra NG; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Ali A; Desai NR; Ahmad T
    Circ Heart Fail; 2019 Nov; 12(11):e006369. PubMed ID: 31707800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of patients implanted with a left ventricular assist device at nontransplant mechanical circulatory support centers.
    Katz MR; Dickinson MG; Raval NY; Slater JP; Dean DA; Zeevi GR; Horn EM; Salemi A
    Am J Cardiol; 2015 May; 115(9):1254-9. PubMed ID: 25772738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of donor variables on heart transplantation outcomes in mechanically bridged versus standard recipients†.
    Urban M; Booth K; Jungschleger J; Netuka I; Schueler S; MacGowan G
    Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):455-464. PubMed ID: 30169835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.
    Kiernan MS; Grandin EW; Brinkley M; Kapur NK; Pham DT; Ruthazer R; Rame JE; Atluri P; Birati EY; Oliveira GH; Pagani FD; Kirklin JK; Naftel D; Kormos RL; Teuteberg JJ; DeNofrio D
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry.
    Ambardekar AV; Forde-McLean RC; Kittleson MM; Stewart GC; Palardy M; Thibodeau JT; DeVore AD; Mountis MM; Cadaret L; Teuteberg JJ; Pamboukian SV; Cantor RS; Lindenfeld J
    J Heart Lung Transplant; 2016 Jun; 35(6):722-30. PubMed ID: 26987599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis.
    Shah P; Birk S; Maltais S; Stulak J; Elmi A; Pagani FD; Cowger JA
    J Heart Lung Transplant; 2017 Jun; 36(6):640-649. PubMed ID: 28087105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    J Heart Lung Transplant; 2019 Feb; 38(2):114-126. PubMed ID: 30691593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Forecasts of Survival for Patients Living With Destination Left Ventricular Assist Devices: Insights From INTERMACS.
    Michelis KC; Zhong L; Peltz M; Pandey A; Tang WHW; Rohatgi A; Young JB; Drazner MH; Grodin JL
    J Am Heart Assoc; 2020 Jul; 9(14):e016203. PubMed ID: 32648531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Evaluations for Heart Transplant Before Durable Left Ventricular Assist Device and Subsequent Receipt of Transplant at Transplant vs Nontransplant Centers.
    Cascino TM; McCullough JS; Wu X; Pienta MJ; Stewart JW; Hawkins RB; Brescia AA; Abou El Ala A; Zhang M; Noly PE; Haft JW; Cowger JA; Colvin M; Aaronson KD; Pagani FD; Likosky DS;
    JAMA Netw Open; 2022 Nov; 5(11):e2240646. PubMed ID: 36342716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry.
    Clerkin KJ; Topkara VK; Demmer RT; Dizon JM; Yuzefpolskaya M; Fried JA; Mai X; Mancini DM; Takeda K; Takayama H; Naka Y; Colombo PC; Garan AR
    JACC Heart Fail; 2017 Dec; 5(12):916-926. PubMed ID: 29191299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.